FDA: Single dose of bivalent COVID vaccine sufficient for most individuals

FDA: Single dose of bivalent COVID vaccine sufficient for most individuals

The Meals and Drug Administration (FDA) on Tuesday introduced it was simplifying its advisable COVID-19 vaccine schedule, stating a single dose of the bivalent vaccine particular to the BA.4 and BA.5 strains of the omicron variant is sufficient for most people.

Going ahead, the FDA introduced all coronavirus vaccines administered to these six months and older can be the bivalent doses. The unique types of the COVID-19 vaccines from Pfizer and Moderna are now not licensed to be used within the U.S., the company mentioned.

The announcement on Tuesday indicated a shift away from the two-dose vaccine schedule that has turn into the usual all through the U.S. on the subject of mRNA vaccination. Johnson & Johnson’s coronavirus vaccine was initially the one licensed shot within the U.S. that was administered in a single dose.

In accordance with the FDA, people who haven’t gotten a bivalent shot but or haven’t gotten vaccinated in any respect are nonetheless eligible for a dose, however those that have obtained a single dose already are “not at present eligible for an additional dose.”

The company says it plans to make additional choices on vaccination suggestions in June concerning the autumn pressure composition of the COVID shot.


Copyright 2023 Nexstar Media Inc. All rights reserved. This materials will not be printed, broadcast, rewritten, or redistributed.

#FDA #Single #dose #bivalent #COVID #vaccine #folks, 1681827357

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top